Effect of Saroglitazar on Glycemic Status: A Meta-analysis
Abstract
Aim: This systematic review and meta-analysis were conducted to assess the glycemic effect of saroglitazar in patients with type 2 diabetes or prediabetes and dyslipidemia. Methods: PubMed and Google Scholar databases were searched for randomized controlled trials and observational studies till December 2023. The primary outcomes were changes in glycemic parameters such as glycated hemoglobin (HbA1c), fasting blood sugar (FBS), and post-prandial blood sugar (PPBS) levels, and the secondary outcomes included changes in lipid profile. The adverse drug reactions were noted and recorded. ROB2 was used for assessing the risk of bias. Results: A total of 147 studies were screened, and 12 studies were included in the review. There was a significant reduction in FBS (-30.16 (95% CI: -40.36, -19.95) p<0.001, I2=98%), PPBS (-69.09 (95% CI: -85.72, -52.46) p<0.001, I2=96%), and HbA1c (-0.93 (95% CI: -1.18, -0.67) p<0.001, I2=99%) levels following saroglitazar treatment. There was also a significant reduction in total cholesterol of -26.15 (95% CI: -42.44, -9.86) p=0.002, I2=98% and -58.25 (95% CI: -72.21, -44.30) p<0.001, I2=94% in the randomized controlled trials and observational studies, respectively. The study found a significant reduction in low-density lipoprotein and very-low-density lipoprotein levels, along with an improvement in high-density lipoprotein levels, in the saroglitazar group. Conclusion: Our meta-analysis has found that saroglitazar causes a significant reduction…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.